The Effects of Polyphenols on Bone Metabolism in Postmenopausal Women: Systematic Review and Meta-Analysis of Randomized Control Trials
Open Access
- 5 October 2023
- journal article
- review article
- Published by MDPI AG in Antioxidants
- Vol. 12 (10) , 1830
Abstract
Osteoporosis is a condition favored by the postmenopausal decline in estrogen levels and worsened by oxidative stress (OS). Polyphenols are natural compounds abundantly found in fruits and vegetables, and they exert antioxidant and hormonal effects that could be useful in osteoporosis prevention, as suggested by epidemiological studies showing a lower incidence of fractures in individuals consuming polyphenol-rich diets. The aim of our meta-analysis is to evaluate the effects of polyphenols on bone mineral density (BMD, primary endpoint) and bone turnover markers (BTMs, secondary endpoint) in postmenopausal women. Twenty-one randomized control trials (RCTs) were included in our analysis after in-depth search on PubMed, EMBASE, and Scopus databases. We found that supplementation with polyphenols for 3–36 months exerted no statically significant effects on BMD measured at lumbar spine (sMD: 0.21, 95% CI [−0.08 to 0.51], p = 0.16), femoral neck (sMD: 0.16, 95% CI [−0.23 to 0.55], p = 0.42), total hip (sMD: 0.05, 95% CI [−0.14 to 0.24], p = 0.61), and whole body (sMD: −0.12, 95% CI [−0.42 to 0.17], p = 0.41). Subgroup analysis based on treatment duration showed no statistical significance, but a significant effect on lumbar BMD emerged when studies with duration of 24 months or greater were analyzed separately. On the other hand, we found a significantly slight increase in bone-specific alkaline phosphatase (BALP) levels (sMD: 1.27, 95% CI [1.13 to 1.42], p < 0.0001) and a decrease in pyridinoline (PD) levels (sMD: −0.58, 95% CI [−0.77 to −0.39], p < 0.0001). High heterogeneity among studies and unclear risk of bias in one third of the included studies emerged. A subgroup analysis showed similar effects for different duration of treatment and models of dual-energy X-ray absorptiometry (DXA) scanner. More robust evidence is needed before recommending the prescription of polyphenols in clinical practice.Keywords
This publication has 75 references indexed in Scilit:
- Effects of soya isoflavones and exercise on body composition and clinical risk factors of cardiovascular diseases in overweight postmenopausal women: a 6-month double-blind controlled trialBritish Journal of Nutrition, 2010
- Effects of ipriflavone on postmenopausal syndrome and osteoporosisGynecological Endocrinology, 2009
- Gender-specific Associations Between Soy and Risk of Hip Fracture in the Singapore Chinese Health StudyAmerican Journal of Epidemiology, 2009
- Soy proteins and isoflavones affect bone mineral density in older women: a randomized controlled trialThe American Journal of Clinical Nutrition, 2009
- Evaluation of Isoflavone Rich Soy Protein Supplementation for ostmenopausal TherapyPakistan Journal of Nutrition, 2009
- Menopausal hormone therapy and risk of ovarian cancer: systematic review and meta-analysisHuman Reproduction Update, 2007
- Incidence and Economic Burden of Osteoporosis-Related Fractures in the United States, 2005–2025Journal of Bone and Mineral Research, 2007
- An estimate of the worldwide prevalence and disability associated with osteoporotic fracturesOsteoporosis International, 2006
- One-year soy isoflavone supplementation prevents early postmenopausal bone loss but without a dose-dependent effectThe Journal of Nutritional Biochemistry, 2006
- SOY ISOFLAVONE TABLETS REDUCE OSTEOPOROSIS RISK FACTORS AND OBESITY IN MIDDLE‐AGED JAPANESE WOMENClinical and Experimental Pharmacology and Physiology, 2004